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The successful transition from the intra-uterine 
environment to the gaseous atmosphere is the first and 
most important task in the life of the newborn. The prob¬ 
lem of oxygenating the tissues is solved in the fetus by 
direct diffusion across the placental membranes, and trans¬ 
port by fetal hemoglobin. Once the lungs have begun func¬ 
tioning, a major adaptation is required in order to ensure 
uninterrupted oxygen transport. This is gradually accom¬ 
plished by the transition from fetal to adult hemoglobin, 
which is more suited to the task of loading oxygen in the 
lungs and releasing it to the tissues during extra-uterine 
life. In both fetus and adult, oxygen is carried to the tis 
sues by a hematological "conveyor belt" which must be re¬ 
sponsive to alterations in oxygen supply and demand. 
This thesis will review the mechanisms by which red 
blood cells accomplish the task of delivering sufficient 
oxygen to supply the needs of the tissues, specific adap¬ 
tations which occur in response to physiological stresses, 
and methods of altering oxygen carrying capacity. The 
clinical significance of the role of 2,3-diphosphoglycerate 
in hemoglobin-oxygen affinity will be emphasized. 
Altered oxygen carrying capacity of the blood may be 
caused by deficient quantities of hemoglobin, alterations 
of metabolism within the red blood cell, and any factor 

-2- 
affecting the affinity Df hemoglobin for oxygen. Methods 
of increasing oxygen transport to tissues have primarily 
consisted of increasing red blood cell mass by means 
of blood transfusions, and increasing cardiac output. 
Attempts to alter hemoglobin-oxygen affinity have only 
recently been investigated. This thesis will present an 
original laboratory investigation done by the author to 
determine the effect of corticosteroids on hemoglobin- 
oxygen affinity. 
\;.E in93 21 
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THE ROLE OF 2,3-DIPH05PH05PHDGLYCERATE IN OXYGEN TRANSPORT 
The Affinity of Hemoglobin for Oxygen 
Tissue oxygenation is dependent upon the oxygen 
content of inspired air, the partial pressure of oxygen 
C p□^ 3 » alveolar ventilation, oxygen diffusion into 
red cells, cardiac output, blood volume, hemoglobin 
concentration, and oxygen diffusion from the blood into 
tissues. The affinity of hemoglobin for oxygen is 
most clearly discussed in terms of the hemoglobin- 
oxygen dissociation curve (FIG. 1). It can be seen that 
at partial pressures of oxygen of 110 mm. Hg which exist 
in the lung, normal adult hemoglobin becomes 95 percent 
saturated with oxygen. There is very little change in 
hemoglobin saturation with increases in the p0,~, greater 
than 1 1 El mm. Hg. lAJhen the partial pressure of oxygen is 
reduced to 27 mm. Hg, hemoglobin is 50 percent saturated. 
This p0„ is referred to as the Pnn. Shifts in the hemo- 
globin-oxygen dissociation curve to the right correspond 
to an increase in P^, while shifts of the curve to the 
left correspond to a decreased P^. Shifts in the curve 
from normal indicate alterations in the affinity of hemo¬ 
globin for oxygen. Factors which decrease the affinity 
includes decreased blood pH (Bohr effect), increased blood 
carbon dioxide content, increased ionic concentration, 
and increased temperature. Increased affinity is found 
68,70 
with increased blood pH, and decreased temperature. 
Y o 
-nr i -f- 
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FIGURE 1 
HEMOGLOBIN OXYGEN DISSOCIATION 
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Decreased hemoglobin-oxygen affinity shifts the 
dissociation curve to the right (increased Pgg)> since a 
higher p0_, is required to maintain the same percent sat¬ 
uration. Conversely, increased hemoglobin-oxygen affinity 
shifts the curve to the left (decreased Pgg)» The physio¬ 
logical significance of decreased hemoglobin-oxygen affinity 
is that more oxygen can be delivered to tissues without a 
reduction in partial pressure of oxygen. Thus, despite a 
decrease in degree of hemoglobin saturation, the end-cap¬ 
illary oxygen gradient is maintained. Bendixen and Laver*3 
place the "average critical range" of p09 to maintain a 
diffusion gradient into tissues between 2D and 30 mm. Hg, 
which corresponds to a hemoglobin saturation of 35-55 per¬ 
cent at normal pH and temperature. It can be seen that a 
right-shifted curve has a much lower degree of saturation 
in the "average critical range" of p09 than does the normal 
curve, and thus would be a highly adaptive response to either 
58 
increased tissue oxygen requirements, or hypoxia. While 
decreased hemoglobin-oxygen affinity is one mechanism to 
increase tissue oxygenation, hypoxia and increased oxygen 
consumption can be compensated for by improved oxygen trans¬ 
port. Increased cardiac output is one way to achieve this, 
but is limited by increased cardiac oxygen consumption. 
The other main mechanism for increasing oxygen transport 
is increased hemoglobin concentration. 
, no x J 





Hemoqlobin Structure and Function 
Each of the two sets of chains present in the hemo¬ 
globin A (alpha2 beta^) molecule contains a heme prosthetic 
group, which is the site of reversable binding with oxygen, 
primarily by hydrophobic bonds. As each heme group becomes 
saturated with oxygen, the subsequent heme group is more 
easily saturated at smaller increments of partial pressure 
of oxygen. Because of this cooperative "heme-heme interac¬ 
tion," 90-100 percent saturation can occur at partial pres¬ 
sures of 60-100 mm. Hg, and oxygen can be readily released 
7 6 
to tissues by small changes in tissue oxygen tension. 
The structure of hemoglobin can be contrasted to that 
of myoglobin, which is a heme containing monomer. There is 
no facilitation of oxygen saturation at increasing partial 
pressures of oxygen, and myoglobin does not release oxy¬ 
gen at normal tissue partial pressures. 
64 
Investigations by Perutz have shown basic differen¬ 
ces in the crystallographic structures of oxygenated and de- 
oxygenated hemoglobin. Studies of nuclear magnetic resonance 
and electroparamagnetic resonance have shown that direct 
heme-heme interaction is mostly due to conformational 
changes in the protein portion of the molecule, mediated 
77 
through subunits by their common interfaces. Thus, 
changes in oxygen affinity of hemoglobin due to tempera¬ 
ture, pH, ionic concentration, and carbon dioxide result 
. I I 
-7- 
from interactions between oxygen binding sites and 
binding sites for other ligands. 
The Interaction Between Hemoglobin and Organic Phosphates 
g 
In 1967, studies by Benesch and Benesch and Chanutin 
20 
and Curnish showed that red cell concentrations of organic 
phosphates had significant effects on hemoglobin-oxygen 
affinity, independent of the effects of temperature and 
pH. 2,3-diphosphoglycerate (2,3-DPG) and adenosine tri¬ 
phosphate (ATP) were shown to bind reversably to hemoglobin 
A (alpha^ betau), and in some way decrease hemoglobin-oxy¬ 
gen affinity. Adenosine diphosphate (ADP) also binds to 
hemoglobin, but does not show as high binding affinity as 
do 2,3-DPG and ATP. 
1 0 
Benesch showed that adding increasing concen¬ 
trations of 2,3-DPG to a solution of hemoglobin results 
in a significant increase in P^ . Thus, an important role 
of 2,3-DPG in red blood cells is to bind to hemoglobin in 
such a way as to decrease hemoglobin affinity for oxygen 
(FIG. 2). 
4 
Bauer et al. have shown that 2,3-DPG and ATP concen¬ 
trations were low in stored blood, and this accounted for 
the increase in hemoglobin-oxygen affinity that occurs with 
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2,3-DPG has a higher binding affinity for deoxygenated 
hemoglobin than for oxygenated hemoglobin, and does not 
bind to met hemoglobin or cyanomethemoglobin. The sig¬ 
nificance of this is that 2,3-DPG apparently selectively 
binds with the deoxy conformation, and stabilizes the 
1 0 
molecule such that its affinity for oxygen is reduced. 
Thus, 2,3-DPG and oxygen effectively compete for the 
deoxy conformation. 
Isolated alpha or beta chains do not bind 2,3-DPG, 
indicating that binding requires complete tetramers. 
2,3-DPG does not bind to alpha-4 tetramers, but does 
bind to beta-4 tetramers (hemoglobin H) less tightly than 
to hemoglobin A, implying that the binding site is on 
g 
the beta chain of hemoglobin. 
Beta-4 tetramers maintain a fixed conformation 
similar to deoxy-hemoglobin, thus reducing heme-heme 
interaction, the Bohr effect, and increasing oxygen af¬ 
finity. 2,3-DPG binding to beta-4 tetramers does not re¬ 
duce oxygen affinity, since beta-4 tetramers are apparently 
g 
in a fixed conformation which is not affected by 2,3-DPG. 
While hemoglobin-2,3-DPG binding can cause shifts in 
the position of the hemoglobin-oxygen dissociation curve, 
the sigmoid shape of the curve is retained because of the 
11,15,2D 
fact that heme-heme interaction is not altered. 
■ ivxc io'i rieri^' nidi I mi: art 
The exact binding site on the hemoglobin molecule 
1 5 
has been described best by Bunn and Briehl , and supported 
33 
by the model of Greer and Perutz . Taking into account 
preferential bindng to beta chains when the molecule is in 
the deoxy conformation, as well as the fact that fetal 
hemoglobin (alpha^ gamma^)? without beta chains, shows 
some reaction with 2,3-DPG, they have proposed that 2,3-DPG 
is bound at the beta 143 histidine, as well as to the 
[\l-terminal amino group of beta and gamma chains. This 
accounts for the strongest binding to beta chains, some 
interaction with gamma chains, and no binding to alpha 
chains. In addition, it appears that the binding sites 
are common for all the organic phosphates, since competitive 
interference can be demonstrated between 2,3-DPG and ATP.1' ,4tj 
2,3-DPG Interaction With Different Hemoglobins 
(Yluch important work on the oxygen affinity of dif- 
1 5 
ferent hemoglobin molecules was done by Bunn and Briehl 
in 1970. LUhen 2,3-DPG was added to a solution of normal 
hemoglobin A, they found oxygen affinity to decrease, as 
indicated by a doubling of PU]q- Hemoglobin F (alpha.-, 
gamma^) which has an uncharged serine in the gamma chain 
replacing the H21 histidine, only had a 2D percent increase 
2 6 
in P^g* Hemoglobin A ^ ^, a minor electrophoretic com¬ 
ponent of Hb A, has a hexose residue bound to the IM-terminal 
jtrn 
j x ib i . sn-CBiio 
groups of the beta chain. This reduces 2,3-DPG binding at 
that site, and consequently the decrease in oxygen affinity 
is only 23 percent. Hemoglobin F_, a minor hemoglobin F 
component, has an acetyl residue covalently bonded to 
the l\l-terminal group of the gamma chain of hemoglobin F, 
and this molecule does not bind 2,3-DPG either on the alpha 
chains Dr the gamma chains, and the oxygen affinity is not 
altered.^ ^ 
Hemoglobin S (alpha2^ beta^"^ solutions 
shorn normal oxygen dissociation and interaction with 2,3- 
DPG. However, in vivo studies of sickle cells have shown 
a shift in the hemoglobin-oxygen dissociation curve to the 
right, apparently as a result of intra-cellular changes, 
6 T T 5 
and not hemoglobin-2,3-DPG interaction.“ Rotman et al. 
have shown oxygen uptake by sickled erythrocytes to be 
18 
decreased. Charache et al. have shown that 2,3-DPG con¬ 
centrations in sickle erythrocytes is increased, apparently 
as a physiological response to the decreased cellular 
oxygen uptake. 
Many abnormal hemoglobins have been found to be 
associated with alterations in Prn without alterations in 
□ u 
8 7 
2,3-DPG concentrations or binding.u However, hemoglobin 
Hiroshima, which has an amino acid substitution for beta 
143 histidine, does show increased affinity for oxygen, 
65 
presumably because of a decreased alkaline Bohr effect, 
but also possibly on the basis of interference with 
.-it .-i.t snai:U--in3c 
• ’ 
i i c . :\.v : . 
- aij! :i?3Ci 
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o nn r i_, • ,• 26,35,38,48 2.3- DPG binding . 
Fetal hemoglobin shows an interesting adaptive 
modification. Because of its diminished interaction with 
2.3- DPG, hemoglobin F has a dissociation curve that is 
shifted to the left of that of hemoglobin A. This al¬ 
lows a greater amount of oxygen to be picked up at the 
partial pressure of oxygen present in the placenta. 
Unloading of oxygen is facilitated by the low partial 
pressure of oxygen in the tissues .')Lj Thus, hemoglobin F 
is uniquely suited to the intra-uterine environment, 
where oxygen must be picked up by hemoglobin at partial 
pressures that are much lower than are found in the lung 
during extra-uterine life. 
It would be expected then, that as more and more 
adult hemoglobin is synthesized, and replaces fetal hemo¬ 
globin during the first few months of life the affinity 
for oxygen would decrease, and the P^ would steadily 
rise. In fact, the P^ does increase steadily during the 
first three months of life,^ but the decrease in oxygen 
affinity does not correlate well with the decrease in 
hemoglobin F concentrations. During the first week of 
life, 2,3-DPG concentrations rise, although the hemo¬ 
globin F concentration does not change. During the se¬ 
cond and third weeks of life, the 2,3-DPG concentration 
returns to the birth level. Thus, while hemoglobin F 
«i i a u') 
-13- 
concentration is continually falling, and 2,3-DPG 
concentrations rise and then fall to birth level, Pm 
bu 
steadily increases (FIG. 3). 
In order to explain this lack of correlation, Delivoria- 
24 
Papadopoulos ' created the concept of "the functioning or 
interacting 2,3-DPG fraction," which takes into account the 
percent Hb A (2,3-DPG cone, x /^Hb A), and shows good cor¬ 
relation with the Prn. Even better correlation between 2,3- 
b U 
54a 
DPG and P^ was demonstrated by Orzalesi and Hay when 
the 40/^ interaction between 2,3-DPG and Hb F is considered 
in addition to the percent Hb A present ("effective DPG 
fraction",]. Thus, any individual infant’s P L ^ is dependent 
upon his particular Hb A: total hemoglobin ratio, and 
total 2,3-DPG concentration. 
The increase in 2,3-DPG concentration during the first 
week of life could presumably be a physiological attempt to 
decrease the high oxygen affinity of hemoglobin F. 2,3-DPG 
levels decline to normal during the second and third 
weeks as Hb A concentrations begin to increase, with con¬ 
comitant decrease in hemoglobin-oxygen affinity. 
Premature infants have a hemoglobin-oxygen dis¬ 
sociation curve which is shifted to the left, and which 
never shifts as far right-ward after birth as does a 
term infant's. This is presumably due to instability of 
the 2,3-DPG molecule of an unknown nature. It has been 
55 
shown that 2,3-DPG mutase is normal in premature infants. 
'ii c z. 09G -C . 
V ^ : i 
- • r- J I , P IP P c'S’-'i 
C i ' ; flX X S . 
s'i i b'lL'j 
-14- 

























QJ ro X X - 
X QJ ro QJ QJ 
i-1 X X p X > 
•iH ro •H P 
x cn i—i X ro G 
o c QJ X U 
g •H p QJ •rH 
p p X X E 
□ 1—1 □ □ X ro G 
LD r-H X u c •rH 
CL ro cn □ p 
X 1—1 * c ••H X 
Q '— 1 X •rH X •rH 
X □ ro X P ro i-i 
<C x X a G i—1 •rH 
i X QJ G 
- c c CTO P CT 
LD •H QJ - X P LlJ 
CL cn X OJ Q_ QJ 1 
CD QJ X a X c 
1 JO X i C QJ 
m X □ X •i—1 CT 
- X c - >, 
CM □ ro c CM QJ X 
c □ X □ 
- QJ ••H C 1— 
Li_ ro ro X •P QJ 
QJ •rH CJ - X 
X □ P- ro QJ X X 
x X p ro CC 
ro X •p X 
2 X >—i p - c 
UJ QJ cn X ro 
LlJ X > c QJ QJ 
=a X QJ •rH X •P - 
i— i—1 C X i—1 c 
LlJ QJ □ X • r| 
CD 1-1 X •rH c X X 
•rH CL X °p □ □ 
CL X O U ro X 
i—i 3 1 C i—i 
X fro G X X E 
cn - - X X (C CL) 
X X CM QJ ro x 
a X 
i—i p X QJ X .. 
f— •P c X □ <=t ro 
<C X ro x c X QJ • 
_J - X T— 
UJ E - ro •p • P o- 
X □ X • QJ <—I cn 
P X QJ □ ro □ T— 
X p X X a X - 
•P • P ro 0- 
>,x i—I X .. X X 
1—1 G E ro 1 
•H P X X □ E DG 
X QJ □ P CO 
ro X - X l-1 •» 
QJ X ro a 1-1 ca 
X ro _Y X QJ - 
ro QJ X ro U 
ro QJ X ro 
ro X 3 X ro X E 
n QJ QJ X CD □ QJ 
ro QJ CTO •H □ X 
UJ •rH 3 3 l-1 
X P X • X » 
x IX ro i-1 PC cn 
X p '-1 QJ X □ 
t—i LD •i 1 QJ QJ CL) p 
X X CM X 3 3 P CL 

-15- 
THE BIOSYNTHESIS OF 2,3-D IPH05PHDGLYCERATE 
AMD ITS REGULATION IN CLINICAL CONDITIONS 
Regulation dp the Biochemical Level 
2,3-DPG synthesis is ultimately dependent on the 
over-all rate of glycolysis. Primary control is depen¬ 
dent on phosphofructokinase (PFK) activity, which is pH 
dependent (FIG. 4). ATP concentrations play a regulatory 
role in that PFK is inhibited by small concentrations of 
ATP, and this inhibition is overcome by alkalosis and by 
5 1 
ADP and inorganic phosphate. Inorganic phosphate and 
NAD are important in the control of glyceraldehyde-3-phos- 
phate dehydrogenase (G3PD) activity. In the presence of 
high pH and inorganic phosphate concentrations, red cell 
glycolysis is increasingly regulated by G3PD activity. In 
the presence of NAD and inorganic phosphate, phospho- 
glycerate kinase (PGK) becomes the major regulatory en¬ 
zyme. PGK activity is dependent on 1,3-DPG concentrations 
30 
and the ATP:ADP ratio. ADP plays a role in regulating 
competition between 2,3-DPG mutase and PGK for 1,3-DPG. 
With higher ADP concentrations, 1,3-DPG is converted to 3- 
phosphoglycerate (3PG), bypassing 2,3-DPG synthesis. 
ATP concentrations will decrease PGK activity. 1,3-DPG 
formation is enhanced by a high pH, high inorganic phos¬ 
phate concentration, and high NAD concentration. 
The synthetic step from 1,3-DPG to 2,3-DPG is 
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catalyzed by DPG mutase, which is strongly inhibited by 
2,3-DPG. 2,3-DPG binding to deoxyhemoglobin with con¬ 
sequent release of product inhibition is now felt to be of 
2 
minimal importance in the stimulation of 2,3-DPG synthesis. 
When 2,3-DPG is synthesized in the red cell, synthesis 
of products distal to 2,3-DPG in the glycolytic pathway may 
be reduced. If pyruvate concentrations decrease, there 
is less substrate for lactic dehydrogenase, the NAD re¬ 
duced by G3PD cannot be reoxidized by lactic dehydrogenase, 
and consequently glyceraldehyde-3-phosphate and dihydroxy- 
acetone begin to accumulate. In hypoxic conditions under 
which 2,3-DPG synthesis is st imulated, tissue lactate and 
pyruvate levels may increase. If pyruvate enters NAD deple¬ 
ted red cells, oxidation of NADH to NAD is facilitated, and 
conversion of G3P and dihydroxyacetone to 1,3-DPG can 
72 
occur. 
2,3-DPG is degraded by 2,3-DPG phosphatase, which 
catalyses the reaction: 
2,3-DPG + H2D --> 3-PG + Pi 
and is activated by chloride and phosphate + chloride, 
but is far less active than DPG mutase in red cells. (/' 
Hypoxia Induced Effects 
lx 2 
Lenfant et al. first showed rapid reversable el¬ 
evations (within 24-48 hours) in 2,3-DPG concentrations 

-18- 
in the red cells of subjects moving from sea level to an 
altitude of 15,000 feet. As mentioned, acidosis shifts the 
hemoglobin-oxygen dissociation curve to the right by the 
Bohr effect, and when subjects are pretreated with an 
acidosis inducing drug such as Diamox, their oxygen re¬ 
leasing capacity is maintained and the physiologic increase 
43 
in 2,3-DPG is suppressed during moves to higher altitudes. 
50 
Recently, lYliller et al . have confirmed Lenfant’s 
findings, and also have proposed that stimulation of 
erythropoietin by hypoxia, alkalosis, and hypocapnia is 
suppressed by rising levels of 2,3-DPG and the resulting 
decrease in hemoglobin-oxygen affinity. They concluded 
that the rise and fall of serum and urinary erythropoietin 
levels after exposure to hypoxia are due to changes in 
hemoglobin-oxygen affinity rather than to bone marrow 
utilization of the hormone. 
In conditions of relatively poor tissue oxygenation 
red cell 2,3-DPG levels are found to be increased in an 
adaptive attempt to facilitate oxygen release from hemo¬ 
globin. Thus, hypoxic conditions secondary to chronic 
56 57 
pulmonary disease, congenital heart disease, chronic 
56 
liver disease, and heart disease with decreased cardiac 
89 
output all have associated elevations in 2,3-DPG. 
3 0 
Huehns and Bellingham J have shown that in hemo¬ 
lytic anemia, there is an inverse relationship between 
1- < -i 
' 
- J I 
nr 
' • * ■ 
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packed cell volume and 2,3-DPG level. Valeri and Fortier 
have shown elevated 2,3-DPG levels in association with 
decreased red cell mass in the absence of law hemoglobin 
or hematocrit levels. 
6 9 
Rodriguez and Shahidi found that 2,3-DPG concen¬ 
trations could be used to differentiate adaptive from 
pathological deficiencies in red cell volume. In patients 
with pathological red cell volume and plasma volume 
deficiencies secondary to panhypopituitarism and to 
growth hormone deficiency, no increase in 2,3-DPG was 
noted. However, increases did occur in normal monkeys 
after growth hormone and thyroxine administration. They 
concluded that both hormones act synergistically to in¬ 
crease 2,3-DPG concentrations. 
The mechanism of 2,3-DPG elevations associated with 
relative arterial hypoxemia is not entirely elucidated, 
3 
but much work has been done in this area. Astrup and 
29 
Duhm and Gerlach have proposed that intracellular pH 
is the primary controlling factor in 2,3-DPG synthesis, 
and the release from product inhibition is of minor 
importance. They propose that with deoxygenation, intra- 
erythrocytic pH rises as a result of hydrogen ion absorp¬ 
tion by deoxyhemoglobin. At higher pH levels, PFK is 
activated, allowing increased glycolysis and 2,3-DPG 
synthesis. At the same time, increased concentrations of 
• E , s‘ \r. ie ; mu Lev IX i 6 
t 9 .1 f- ' 91 9 n ui d r: s 3 v e rt 
n. 
i L. iiaecji ms 
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deoxyhemoglobin are available for 2,3-DPG binding, and 
any degree of product inhibition present can be overcome. 
In patients with splenomegaly, 2,3-DPG levels are 
reduced, presumably due to accelerated degradation and 
impaired red cell glycolysis secondary to erythrocyte 
sequestration, and the acid environment of the enlarged 
spleen.c^ 
The Effect of Inorganic Phosphate 
45 82 
Lichtman et al . and Travis found decreased red 
cell glycolysis, decreased 2,3-DPG and ATP levels and 
increased hemoglobin-oxygen affinity caused by hypo- 
44 
phosphatemia. Lichtman also studied uremic patients with 
hyperphosphatemia and as expected found them to have elevated 
ATP and 2,3-DPG levels. These results correlate well 
1 9 
with the study done by Card and Brain, who found a 
closer correlation between serum phosphate levels and total 
organic phosphate level than 2,3-DPG level alone. They 
studied 62 children, and proposed that the "normally 
elevated" plasma inorganic phosphate level of children 
causes elevated red cell organic phosphates, a right 
shifted dissociation curve, and accounts for the re¬ 
sulting "physiologic anemia of childhood." 
55 
Oski and Gottlieb have concluded that, "the red 
cell 2,3-DPG level in vivo appears to be controlled by 
~ I 
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a number of factors which include: the pH, the ratio of 
deoxy to oxy-hemoglobin, the serum inorganic phosphate con¬ 
centration, and the level of plasma oxidants." 
Alterations in Red Cell IHetabolism 
2,3-DPG concentrations have been found to be ele- 
49 
vated in hyperthyroidism. The mechanism of this in¬ 
crease is not related to hypoxia, but rather either to 
increased tissue oxygen consumption, or direct stimulation 
of enzymes involved in 2,3-DPG synthesis. Snyder and 
79 
Reddy found that triiodothyronine directly stimulates 
diphosphoglycerate mutase. 
Since 2,3-DPG synthesis is a branch of the glycolytic 
pathway (FIG. 4), metabolic alterations in glycolysis 
will affect 2,3-DPG synthesis. In subjects with metabolic 
defects proximal to 2,3-DPG in the Embden-lYlyerhof pathway 
such as hexokinase (HK) or glucose isomerase deficiency, 
low levels of 2,3-DPG and an associated decrease in Prn 
b u 
57 
will be found.^ In subjects with pyruvate kinase (PK) 
deficiency which would cause a block in the metabolic path¬ 
way distal to 2,3-DPG synthesis, high levels of 2,3-DPG 
are found. Interestingly, these individuals (PK de¬ 
ficient) require only a small increase in cardiac out¬ 
put to tolerate the same amount of exercise that requires 
58 
doubling of cardiac output in a HK deficient patient. 
rlauc 
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Nelson and Benson studied 20 Down's syndrome 
patients, and found 2,3-DPG levels to be significantly 
higher than in 20 controls. A possible mechanism of this 
increase is marked increase in the activity of erythrocyte 
PFK found in Down's syndrome. 
34 
Guest and Rapoport in 1948 reported decreased 
2,3-DPG levels in comatose diabetics. In 1972, Ditzel"’ 
studied diabetics recovering from acidosis and found that 
louu 2,3-DPG levels in patients who were acidotic returned 
toward normal as their acidosis was corrected. His 
explanation was that in acidosis, 2,3-DPG levels will 
fall because of deactivation of glycolytic enzymes. At 
low 2,3-DPG concentrations, the hemoglobin-oxygen affinity 
will rise, counteracting the acidotic right-ward shift 
of the Bohr effect. When the acidosis corrected, the 
hemoglobin-oxygen dissociation curve does not shift right- 
ward until the 2,3-DPG concentration begins to rise. 
27 
In addition, Ditzel has reported that hemoglobin- 
oxygen dissociation curves in ambulatory diabetics are 
shifted to the left sufficiently enough to cause 30 per¬ 
cent less oxygen release than in normal controls. In non- 
acidotic diabetics, Ditzel based the mechanism of low 
2,3-DPG levels on chronic hyperglycemia. With excess 
glucose, sorbitol and fructose concentrations in red cells 
52 
increase, and the utilization of NADPH in the conversion 
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□f glucose to sorbitol drives the hexose monophosphate 
shunt. As glycolysis via the Embden-lYlyerhof pathway 
declines, 2,3-DPG concentrations fall. 
However, three other separate researchers have been 
unable to reproduce Ditzel's findings in ambulatory dia¬ 
betics, and reported no significant change in red cell 
1.40 71 
2,3-DPG concentrations. ’ ’ 
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THE PHARMACOLOGICAL fYlAlM IPULA TI ON OF 2,3-DIPH05PHDGLY CE RATE 
The Use of Inosine in Stored Blood 
16 
In 1969, Bunn et al . were able to relate the 
progressive increase in hemoglobin-oxygen affinity 
during the first days of storage of blood in acid- 
citrate-dextrose solutions at 4° C to a decline in red 
cell levels of 2,3-DPG and ATP. This decline was not 
observed in blood stored in citrate-phosphate-dextrose 
2 1 
solution. The 2,3-DPG decline could also be reduced 
if inosine is added to the solution, if the pH is main¬ 
tained at normal levels, and if the hemoglobin is in the 
37 
deoxygenated state. If the blood is frozen, 2,3-DPG 
9 1 
levels can be maintained for long periods. 
In patients transfused with ACD stored blood, there 
is a marked shift in their hemoglobin-oxygen dissociation 
85 
curve to the left, which reverts back to about 50 per¬ 
cent of normal within 6 to 24 hours after transfusion, 
7 84 
as 2,3-DPG is resynthesized. ’ In healthy subjects 
transfusions generally do not cause a clinical problem. 
However, in critically ill patients massive transfusions 
(op to 25 units) of ACD blood lowers the P^g by 8.6 mm. 
1 4 
Hg, and in order to deliver sufficient oxygen to tissues, 
these patients must compensate by increasing cardiac 
58 
outpot. In soch cases, Oski et al. has shown the clini¬ 
cal advantage of a right-ward shift of the dissociation 
corve . 




Os ki et al/'^1 found they could restore 2,3-DPG levels 
to normal in 2,3-DPG depleted blood by adding inosine, 
pyruvate, and phosphate. They noted that this effect 
uuas related to the purine nucleoside phosphory 1 ase activity 
of different species. In dogs, which have no PNP-ase 
activity, there was no rise in the 2,3-DPG level. 
8 D 
In a follow up study, Sugerman et al. observed 
a 51 percent increase in 2,3-DPG con certr at i on in Rhesus 
monkey erythrocytes 6 hours after an infusion of inosine, 
pyruvate and inorganic phosphate. Controls infused with 
saline had no rise in 2,3-DPG. No change in pH was noted. 
The mechanism of the rise is the conversion of inosine 
to hypoxanthine and ribose-1-phosphate (R-1-P). R-1-P 
can be converted to R-5-P, which enters the hexose 
monophosphate shunt, and via transketolase and trans¬ 
aldolase can be converted to fructose-6-phosphate and 
glyceraldehyde-3-phosphate. 
The role of pyruvate in the solution is to allow 
for the oxidation of NADH to NAD, which as previously 
mentioned, is necessary for the conversion of G-3-P 
to 1,3-DPG. 
The use of inosine in man would require simul taneous 
administration of a potent uricosuric agent, such as 
allopurinol, since in the absence of uricase large 
amounts of uric acid and xanthine, breakdown products of 
hypoxantine, would accumulate. 
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Propanolol and (Ylembrane Interaction 
6 3 
Pendletcn et al. J observed that propanolol shifts 
the hemoglobin-oxygen dissociation curve to the right. 
They also noted an accompanying decrease in red cell 
volume, slight increases in 2,3-DPG concentrations per 
millilitre of red blood cells, and slight decreases in 
2,3-DPG concentrations per gram of hemoglobin. Glucose 
utilization by red cells was decreased in the presence 
of propanolol. They concluded that the mechanism of action 
is not mediated by the beta-blocking adrenergic effect 
of propanolol since three other beta-blocking agents, 
INEPA, IY1J 1999, and KQ 592, did not alter the dissociation 
curve. Nor is it mediated by direct action on hemoglobin, 
since there is no effect of propanolol on solutions of 
hemoglobin. Since alterations in red cell morphology 
were noted, and since the effect mas observed immediately 
after the addition of propanolol, they proposed that there 
is an unspecified effect on the red cell membrane. 
59 
Oski et al. also found that propanolol does not 
alter total red cell 2,3-DPG content, does not alter the 
dissociation curve of pure solutions of hemoglobin or 
2,3-DPG depleted blood. They did find that about 3D per¬ 
cent of the 2,3-DPG is bound to the red cell internal 
membrane, and therefore is unavailable for interaction 
with hemoglobin. The "bound fraction" apparently serves 
^ 
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as a reserve, which can readily be made available. In 
propanolol treated red cells, percent of the 2,3-DPG 
is in the "unbound fraction," which would account for the 
right shifted curve. They also found that epinephrine 
prevents the unbinding, implying that the membrane is 
responsive to vasoactive agents. Since propanolol is 
a beta adrenergic blacking agent, Oski speculated that 
there may be adrenergic receptor sites on the red cell 
membrane. These findings have been disputed by Brann 
1 3 
and Newman, who have not been able to find any 
"membrane-bound" 2,3-DPG in erythrocytes. 
7 8 
A recent abstract by Schrumpf et al. reports 
significant elevations of P^g in patients with angina 
pectoris and coronary artery disease being treated with 
propanolol. They speculated that the beneficial effect 
of propanolol in these patients may be due to increased 
oxygen delivery to the myocardium as well as to the 
negative chronotropic effect. 
The Effect of Steroids 
Means of bypassing the need for transfusions by 
the use of erythropoietin-stimulating agents were studied 
22 
by DeGowin et al . They were able to derronstrate increases 
in hematocrit and plasma erythropoietin levels in one 
patient with chronic renal failure treated with hemo- 
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dialysis and testoserone, but no transfusions. No 
increases mere seen in similarly treated anephric 
3 1 
patients. 
In a larger series, Richardson et alwere able 
to eliminate the transfusion requirements in 13 of 15 
patients with chronic renal failure treated with testos¬ 
terone for 5-44 weeks. 
An in vitro study has shown that 11 ketopregnanolone 
12 
is an effective inducer of erythroblast multiplication. 
Another report has found a direct erythropoietic response 
to testosterone without concomitant rises in erythropoietin 
17 
levels o 
In 1972, Parker et al.^ reported a significant 
rise in 2,3-DPG levels in six patients with chronic renal 
failure treated with testosterone for 12 weeks. They found 
no alterations in serum inorganic phosphate levels to 
account for this rise, and suggested only that androgens 
may have a direct metabolic effect on red cells, or an 
indirect effect by altering oxygen consumption. P^'s 
were not studied. 
5 
Bauer and Rathschleg-5chaefer had. .previously 
demonstrated that in vivo administration of aldosterone 
and cortisol to rabbits results in elevations of P 
5 U 
but they did not study 2,3-DPG levels. They concluded 
that the steroid action was not due to a direct effect 
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□n red cells since their results were not reproducible 
with in vitro red cell experiments. 
Significant elevations in 2,3-DPG levels have been 
25 
reported by Desai et al. in Rhesus monkeys after a four 
week administration of testosterone and 11 ketopregnanolone, 
but no increase after estradiol. They did not observe 
any change in hemoglobin, red cell mass, or serum in¬ 
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The purpose of this study is to determine the 
effect of corticosteroids on 2,3-diphosphoglycerate 
levels in human erythrocytes. The relationship of this 
effect to hemoglobin-oxygen affinity will be evaluated, 
and other studies on the pharmacological manipulation 
of 2,3-DPG will be discussed, as well as possible 
mechanisms of action. 
METHODS AND MATERIALS 
Two groups of outpatients being treated in the 
Pediatric Clinic of the Yale-New Haven Hospital were 
studied during the period from January to September 1973. 
Group I 
Group I consisted of children being treated with 
chronic prednisone therapy for nephrotic syndrome. All 
patients in this group had a diagnosis of lipoid nephrosis 
(by renal biopsy) or chronic glomerular nephritis. There 
was no attempt made to disqualify patients from the study 
on the basis of whether or not they had proteinuria at 
the time of blood sampling. Patients with any respiratory 
illness, smokers, or other conditions known to alter hemo¬ 
globin-oxygen affinity were not included in the study. 
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17 patients with a mean age of 8.0 years (8 girls, 
9 boys) were being treated with prednisone at dosages 
from 0.1 mg/kg/day to 2.3 mg/kg/day (mean=0.99 mg/kg/day). 
The duration of continuous treatment varied from one 
month to ten months, with a mean of 4.8 months. 
20 patients with a mean age of 10.9 (9 girls, 
11 boys) with nephrotic syndrome who had not been treated 
with steroids for at least three weeks prior to the 
study served as controls. 
Laboratory determinations of 2,3-DPG, hematocrit, 
and pH were done on venous samples of blood in this group. 
Group II 
10 patients (6 girls, 4 boys) between the ages of 
four and eight (mean age=5.9 years) with acute lympho¬ 
blastic leukemia in remission who were undergoing elective 
reinduction of remission were studied. These patients 
were being treated with prednisone (1.5-2.2 mg/kg/day 
2 
orally) and with vincristine (1.5 mg/m /week intra¬ 
venously) for three weeks, followed by one week of steroid 
tapering. 
Venous blood simples were obtained as follows: 
1. Samples taken prior to reinduction, while 
patients were still on maintenance therapy 
(methotrexate, cytoxan, and cytosine arabinoside). 
-:fiinn,ri 
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2. Samples taken during reinduction with 
prednisone and vincristine. 
3. Samples taken at least two weeks after steroid 
therapy had been discontinued, and maintenance 
therapy had been resumed. 
In addition, samples were obtained from three 
patients (l girl, 2 boys) aged 5, 13, 14 years, who were 
being treated with vincristine but no prednisone, for 
at least 3 weeks . 
Laboratory determinations of 2,3-DPG concentration, 
hematocrit, hemoglobin concentration, and serum inorganic 
phosphate concentration were done in this group. 
Blood Sampling Technique 
Six cubic centimeters of venous blood were obtained 
from each patient by simple veni-puncture, and drawn into 
a plastic syringe. 2 cc of whole blood were heparinized 
and placed in an ice bath during the transport to the 
laboratory for 2,3-DPG analysis. 1 cc of heparinized 
blood was used for hematocrit and hemoglobin determinations. 
2,3-DPG Assay 
Red cell 2,3-DPG concentrations were determined 
by the reduced NADP method^ employed by the Sigma 
Chemical Company Kit, "Ultraviolet Determination of 
2,3-DPG in Blood at 340 mu." 
anxiei" t s 'es • • X3 
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The assay is done an a protein free filtrate pre¬ 
pared from fresh whole blood as follows; 
1.0 ml of heparinized whole blood is pipetted 
into 3.0 ml of cold trichloroacetic acid. 
The mixture is shaken vigorously, and allowed 
to precipitate for 5 minutes, and then centri¬ 
fuged for 10 minutes at 3000 RPlYi. The clear 
supernatant is then used for the 2,3-DPG assay, 
or may be stored at 0-4° C for up to two weeks. 
The test solutions are made by mixing in a cuvette the 
following; 
2.5 ml of a solution of 1.0 mg DPNH in 8.0 ml 
of triethanolamine buffer. 
0.1 ml ATP solution (100 mg/ml) 
0.25 ml of the protein free filtrate 
0,02 ml Glyceraldehyde phosphate dehydrogenase 
(GAPD) and phospho-glyceric phosphokinase 
(PGK) suspension in ammonium sulfate. 
0.02 ml Phosphoglycerate mutase enzyme suspension 
in ammonium sulfate, (PGfYl). 
The blank solution is made by mixing in a cuvette exactly 
the same mixture as in the test solution, except that 
0.25 ml of distilled water is used instead of 0.25 ml 
of the protein free filtrate. 
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A 
At this time, the optical density (0D)(lst reading) 
□f both the blank and test solutions is read on a Beckman 
DU-2 spectrophotometer using potassium chromate (30 mg/ 
1000 ml) as reference at 340 mu. 
0.1 ml of phosphoglycolic acid is thenadded to each 
cuvette. The mixture is allowed to stand for 25-30 min¬ 
utes at room temperature for the reaction to go to com¬ 
pletion. Then the 0D (2nd reading) is read at 340 mu 
of the blank and test solutions, using the same reference 
as before . 
Calculations: 
1. A 0D blank = 0D of blank (1st reading) - 0D of 
blank (2nd reading) 
2. a 00 test = 0D test (1st reading) - 0D test (2nd 
reading) 
3. aOD = (A0D test) - (^0D blank) 
4. umoles 2,3-DPG/ml whole blood = (A0D)(3.0 )_ 
(6.22j(0.0625) 
= (^0D)(?.?) 
3.0 =volume of solution in cuvette 
6.22 =m[Ylolar extinction coefficient for B-DPNH 
at 340 mu 
0.0625 = volume of original sample in reaction 
mixture in ml. 
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Reactions: 
1. 2,3-DPG is hydrolyzed to 3-PG by the reaction: 
2,3-DPG 3-PG + Pi 
2.3- DPG phosphatase activity is present in solutions of 
purified phosphogly cerat e mutase (PGUd). P h asp h og ly co 1 i c 
acid acts as a stimulator of this reaction. 
2. 3-phosphoglycerate (3-PG) is then converted to 
1.3- DP G: 
3-PG + ATP —1,3-DP G + ADP 
3. 1,3-DPG is converted to glyceraldehyde-3-P: 
1 , 3-DPG + DPI\1H ----4 G-3-P + Pi + DPN 
1AJhien DP(\IH (l\IADH) is oxidized to DPN (NAD), there is a 
resultant decrease in the optical density at 340 mu. 
Measuring this ^0D is an indirect measurement of the 
amount of 2,3-DPG originally present. 
pH Determination 
pH determinations mere done on heparinized blood 
samples in duplicate by the Radiometer PH1Y1 71 Acid- 
Base Analyzer. 
1 \ 1' K 
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Heparinized bleed from the same sample used for 
the 2,3-DPG assay was centrifuged in micro-hematocrit 
capillary tubes (Fisher Scientific Co.] in a hematocrit 
centrifuge (international Equipment Co. (Ylo del HIM) for 
five minutes. Hematocrits were read on a micro-capi11ary 
hematocrit reader (international Eqoipment Co.I. 
Hemoglobin Determination 
0.02 ml heparinized whole blood was added to 5.0 ml 
Drabkin’s solution, mixed and allowed to stand for 10 
minutes. Optical density was read on a Beckman DU-2 
spectrophotometer at 540 mu, using Drabkin's solution 
as blank. 0D is multiplied by a correction factor of 
38.6 to obtain grams of hemoglobin per 100 ml. 
Inorganic Phosphate Determination 
Serum inorganic phosphates were determined on serum 
which was frozen immediately after the blood had been 
drawn by the auto-analyzer of the Chemistry Laboratory 
of the Yale-IMew Haven Hospital. 
' 
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RE 5 LILTS 
Group I - Chronic Prednisone Therapy 
2,3-DP G Levels: 
The 2,3-DPG concentra tion of the treated subjects 
was 5162_+213 nmoles/ml RBC (me an+5 . E . IY1. ) , which was 14.□ 
percent higher than the control level of 4527^146 nmoles/ 
ml RBC. When analyzed by Student's t test, this difference 
was highly significant (p<.0l). These results are shown 
in Table 1. 
Figure 5 shows the relationship between the dose 
of prednisone per kilogram body weight and 2,3-DPG con¬ 
centration. The solid line shows the correlation between 
dose and 2,3-DPG level of all patients in this group* and 
was found to be significant (r=.6113, p<.0l). Three 
patents on steroids had proteinuria at the time of blood 
sampling, and it can be seen that these patients had 
higher 2,3-DPG levels at lower steroid dosages (solid 
circles FIG. 5). The correlation between prednisone 
dose and 2,3-DPG level is more significant when the three 
patients with proteinuria are not included with the other 
14 patients on steroids who did not have proteinuria 
(r=.786D, p<.001)(broken line FIG. 5). 2,3-DPG levels 
were not significantly different when analyzed by 
Student's t test between patients with proteinuria and 




Chronic Prednisone Therapy 
CONTROL TREATED_g % INCREASE 
2,3-DP G 
(nmoles/ml RBC) 4527+146* 5162+213 < .01 14,0 
Hemat ocrit 
(°/o) 38.6+1.4 44.4+0.8 <.005 15.0 
pH 7.38 7.39 N.5.** 
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(5757+143 ( n = 3) vs. 5034+596 (n=14)), or the central 
group (4463^297 (n = 8) vs. 4542^218 (n=12)). 
There was ne significant difference in 2,3-DPG levels 
between boys and girls in either the treated or the control 
group. 
There was no significant difference in mean pH 
between the treated (7.39) and the control group (7.38). 
Hematocrit Levels: 
The hematocrit of the treated group was 44.4+0.8 
penEnt, while the hematocrit of the control group was 
38.6_+1.4 percent (mean+5 . E . IY1. ) , an elevation of 14.9 
percent which was significant (p <. 005)(Table l). 
Group II - Acute Prednisone Therapy 
2,3-DPG Levels: 
The 2,3-DPG concent r at i ons (mean_+S . E . IY1. ) before 
therapy, after 1-2 weeks and 3 weeks of prednisone therapy, 
after 1 week of steroid tapering, and after 2-3 weeks off 
therapy are shown in Table 2. The 2,3-DPG concentration 
of three patients on vincristine alone is also shown 
in Table 2. 
Figure 6 shows the linear rise in 2,3-DPG con¬ 
centration associated with acute prednisone therapy. After 
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three weeks of therapy, 2,3-DPG levels rose 21.3 percent, 
which when analyzed by Student's t test is statistically 
significant (p<.02). Comparison of the rise and sub¬ 
sequent fall in 2,3-DPG levels by Scheffe's method for 
comparison of two or more groups shewed a significant 
quadratic effect (p<.Dl). 
There were no significant differences between 
2,3-DPG levels of boys and girls noted. 
Hematocrit and Hemoglobin Levels: 
Figure 7 shows the linear effect of prednisone 
therapy on hematocrit and hemoglobin levels. After three 
weeks of therapy, hematocrit levels were 13.0 percent 
higher than before therapy, which was statistically 
significant (p<.005). 
Hemoglobin levels were 2.0 percent higher after 
three weeks of therapy, which was not a significant 
increase by Student's t test. Hematocrit and hemo¬ 
globin levels are tabulated in Table 2. 
There were no significant differences found between 
boys' and girls* hemoglobin or hematocrit levels. 
Serum Inorganic Phosphate Levels: 
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Figure 6, and tabulated in Table 2. l\lu significant change 
occurred in inorganic phosphate levels during prednisone 
therapy, as analyzed by Student's t test. However, there 
was a decline in inorganic phosphate concentrations during 
the first two weeks of steroid therapy, which returned to 
pre-therapy levels by the third week of treatment, and 
continued to rise after therapy had been discontinued. 
DI5CU55IDN 
This study provides the first reported observation 
of a potent pharmacological manipulation of 2,3-diphospho- 
glycerate concentrations in human red blood cells that 
is dose related. In addition, this study provides evidence 
that prednisone has a significant time related effect on 
2,3-DP G levels . 
5 *7 
Oski et al. have shown that a 430 nmole/ml RBC 
increase in 2,3-DPG concentration corresponds to a 1 mm. 
Hg increase in P^. Therefore, the chronic therapy 
group would have a hemoglobin-oxygen dissociation curve 
that is shifted 1.5 mm. to the right, and the acute therapy 
group would have a curve that is shifted 2.6 mm. to the 
right . 
If the normal dissociation curve is shifted 
2 mm. to the right, oxygen release to the tissues would 
increase by approximately 20 percent, without any decrease 
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in the normal tissue capillary end-oxygen pressure of 
39 mm. Hg. The oxygen extraction required by most tissues 
is about 5 volumes percent, which is adequately provided 
at the position of the normal dissociation curve. 
It has been shown that in an anemic patient, with 
a hemoglobin concentration of 7.5 gm/100 ml and an 
unshifted curve, only about one-half of the oxygen 
content normally extracted would be released to the 
tissues. Shifting the curve 4 mm. to the right allows 
an increased oxygen extraction from 2.5 to 3.5 volumes 
percent, or an increased oxygen delivery to tissues of 
40 percent. Tissue capillary end-oxygen pressure would 
remain at 39 mm. Hg, well above the critical tension 
8 1 
required for adequate oxygen diffusion into tissues. 
In this study, we can assume that there was no 
effect of vincristine on 2,3-DPG levels since the patients 
treated with vincristine alone did not have significantly 
different 2,3-DPG levels from the pre-treatment level. 
The higher hemoglobin and lower serum inorganic phos¬ 
phate levels of the vincristine group can be accounted 
for by the relatively older age of these patients. 
Determinations of pH, hematocrit, hemoglobin and 
serum inorganic phosphate levels were done in order 
to elucidate possible mechanisms of action of prednisone. 
ni 
■ ' u: 
, 9 v "s n: 
. min s j ,u i 3.'*i Jii Txri ?. .asussii 
"2 lUOS'I 
-48- 
Since there was no significant difference between the pH 
of the control and treated samples in the chronic therapy 
group, elevated 2,3-DPG levels were not due to alkalosis. 
Significant elevations in hematocrit in both groups, 
and slight increases in hemoglobin confirm studies that 
12 17 
show steroid induced erythrocytos is . ’ While it 
has been shown that low hematocrit and hemoglobin levels 
3 
are associated with high red cell organic phosphate levels, 
elevated 2,3-DPG concentrations found in this study 
cannot be attributed to anemia. 
Serum inorganic phosphate levels have been shown 
to have a significant effect on red cell organic phosphate 
1 9 
concentrations. Card and Brain found that serum inorganic 
phosphate levels do not correlate as well with 2,3-DPG 
levels as they do with red cell ATP levels in conditions 
characterized by increased serum inorganic phosphate 
concentration. 
As discussed earlier, inorganic phosphate and ADP 
serve to overcome ATP-induced inhibition of PFK, and 
inorganic phosphate and NAD regulate G-3-PD activity. 
In the presence of hypoxia or other stimulation of 
2,3-DPG synthesis not due to elevated inorganic phos¬ 
phate, we would expect increases in 2,3-DPG in preference 
to ATP, since the 2,3-DPG synthetic pathway bypasses 
an ATP producing step in the Embden-IYlyerhof pathway. 
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This would effectively lower ATP levels and facilitate 
release of ATP inhibition of PFK. (FIG. 4) 
In the absence of hypoxia, 2,3-DPG synthesis is 
not facilitated by release of product inhibition of 
2,3-DPG mutase, or by high pH, and we would expect to 
find increases in ATP in preference to 2,3-DPG. This 
would explain the correlation found by Card and Brain, 
as mentioned above. 
In the acute therapy group, decreased serum 
inorganic phosphate levels were observed during the 
first two weeks of steroid therapy as 2,3-DPG levels 
steadily rose. Therefore, we can conclude that predni¬ 
sone does not act by elevating inorganic phosphate 
concentrations and thereby stimulate organic phosphate 
synthesis . 
llle can speculate that the decline in inorganic 
phosphate levels is due to increased 2,3-DPG synthesis. 
A similar temporal relationship between rising 2,3-DPG 
levels and declining inorganic phosphate levels was noted 
8 2 
by Parker et al. during androgen therapy, but they 
did not speculate on the mechanism of this effect. 
90 
Young et al. observed a significant decline in serum 
inorganic phosphate level from 3.68 to 2.41 following 
initiation of resynthesis of 2,3-DPG in patients with 
I. Xu qiu c. hi i 
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Idui 2,3-DPG concentrations secondary to transfusions 
during cardiac surgery. Their explanation is that 
bony and other phosphate stores do not maintain plasma 
phosphate concentrations when exit from the plasma is 
accelerated by utilization in the synthesis of organic 
phosphates. They also noted decreased ATP levels in 
these patients, which they conclude may be due to 
hypoxia induced 2,3-DPG synthesis and bypassing of the 
ATP producing step. This mechanism would apply equally 
well to the observations of the present study. 
Further evidence for the validity of this 
79 
hypothesis is the study by Snyder and Reddy, who 
have shown that 2,3-DPG synthesis is specifically 
stimulated by the activation of 2,3-DPG mutase by 
triiodothyronine, which is also associated with increased 
32 
P uptake by red blood cells. 
Two studies have shown inhibitory effects of 
2 54 
steroids on glucose-6-phosphate dehydrogenase, ’ 
If this were to occur in red cells, it would make 
increased G-3-P concentrations available, but would 
not necessarily account for selective increases in 
2,3-DPG. LUeber et al. have shown a dose related 
increase in fructose diphosphatase and glucose-6- 
phosphatase after hydrocortisone administration. 
. [ C ' . 
XX r 
i 
. IU. '3rl2 
J IP . rzi >! X j C; U 
: J L {' 
-51- 
It is apparent that steroids have potent effects on 
glycolysis which could stimulate 2,3-DPG synthesis by 
enzyme induction, but there is little direct evidence 
for the mechanism by which 2,3-DPG levels specifically 
may be altered. Increased glycolysis in the tissues 
could create increased oxygen consumption, and elevations 
in 2,3-DPG would represent a physiological adaptation to 
that stress. This mechanism for increased 2,3-DPG levels 
in this study cannot be ruled out by the data presented. 
Steroid interaction with red cell membranes was 
2 8 
suggested by Drykorn, who found prednisone to in¬ 
crease survival time of red cells in patients with de¬ 
creased survival time due to chronic anemia, based on 
evidence that prednisone stabilizes cellular membranes. 
The hematological response to androgens has also 
been studied in patients with sickle cell anemia. One 
study reported a clinically beneficial response to androgens 
in 80 percent of treated patients as measured by a de- 
39 
crease in number of painful sickle cell crises. The 
mechanism of this effect, as elucidated by electron 
micrographic studies of sickle cell membranes, is related 
to sol-gel transformations of the hemoglobin molecule 
within the cell, and stabilization of the red cell 
membrane. Significant increases in hemoglobin and 
; b u i 
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hematocrit were also found in androgen treated patients 
4? 
with sickle cell anemia. However, neither of these 
studies analyzed hemoglobin-oxygen affinity or 2,3-DPG 
levels . 
It is not clear how steroid-induced red cell 
membrane stabilization would affect 2,3-DPG function, 
however in view of recent evidence of interaction 
59 
between red cell membranes and 2,3-DPG, this mechanism 




The significance of the role of 2,3-diphospho- 
glycerate in oxygen transport has been firmly estab¬ 
lished. In the past six years, extensive work has 
shown that many clinical conditions are characterized 
by alterations in red cell 2,3-diphosphoglycerate con¬ 
centrations. While at present 2,3-DPG levels are not 
generally used as a diagnostic test, it is not incon¬ 
ceivable that determinations of 2,3-DPG concentrations 
in conditions such as chronic lung disease, cyanotic 
heart disease, and anemia may be valuable in assessing 
the severity of the disease. Certainly, 2,3-DPG levels 
are an important index of the oxygen carrying capacity 
of stored blood. 
Pharmacological manipulation of hemoglobin-oxygen 
affinity by means of restoration of 2,3-DPG in depleted 
cells has been successful in stored blood. In conditions 
such as chronic lung disease, cyanotic heart disease, 
coronary artery disease, and anemia, in which tissue 
oxygenation may be compromised, increased oxygen release 
from hemoglobin could be beneficial. While decreased 
hemoglobin-oxygen affinity could conceivably be helpful 
in neonatal respiratory distress syndrome, elevations 





because of the poor interaction between 2,3-DPG and 
hemoglobin F. Although we can look forward to the 
development of effective therapeutic means for the 
regulation of hemoglobin-oxygen affinity, further 
investigation must be done to determine if such regu¬ 
lation would significantly alter the natural history 
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